September 14 - 17, 2017   Chicago Marriott Downtown Magnificent Mile

Agenda

Thursday, September 14

8:00 AM Breakfast & Exhibits
9:00 AM Symposium Welcome
William Gradishar, MD
SESSION 1
Supportive Issues or Art of Oncology
Session Chair: Nora Hansen, MD
9:15 AM Current Pain Management Guidelines
Judy Paice, PhD, RN
9:45 AM The Imperative of Mandated Care Models
Julia Trosman, PhD, MBA
10:15 AM Can Weight Loss and Increased Physical Activity Reduce the Risk of Breast Cancer Recurrence?
Jennifer Ligibel, MD
10:45 AM Break
11:00 AM Computer Based Physician Support in Breast Cancer Decision Making
Andrew Seidman, MD
11:30 AM Q&A
11:45 AM Lunch Break
SESSION 2
Breast Pathology for the Non-Pathologist
Session Chair: Kalliopi Siziopikou, MD, PhD
1:00 PM Do All High Risk Lesions Still Require Surgical Excision?
Stuart Schnitt, MD
1:30 PM Classic and Newer Multiparametric Prognostic and Predictive Markers for Breast Cancer
Dennis Sgroi, MD
2:00 PM Assessment and Prognostic Significance of Residual Tumor Burden after Neoadjuvant Chemotherapy
Fraser Symmans, MD
2:30 PM Lobular Carcinoma in Situ (LCIS): Current Concepts and Challenges
Tari King, MD
3:00 PM Q&A
3:15 PM Break
SESSION 3
Challenging Clinical Cases
Session Chair: William Gradishar, MD
3:45 PM Challenging Clinical Cases
William Gradishar, MD
5:00 PM Welcome Reception

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts

Friday, September 15

7:30 AM Breakfast & Exhibits
SESSION 4
Imaging and Risk
Session Chair: Sally Friedewald, MD
8:30 AM Refining Indications for PET Scanning: Present and Future
Gary Ulaner, MD
9:00 AM MRI: What is the evidence?
Lawrence Solin, MD
9:30 AM Understanding and Managing Genetic Risk Beyond BRCA
Mark Robson, MD
10:00 AM Break
10:30 AM Topical Approaches to Chemoprevention
Seema Khan, MD
11:00 AM Q&A
11:15 AM DISTINGUISHED LECTURER
Targeting the Breast Cancer Genome and the Shaping of Precision Medicine
José Baselga, MD, PhD
12:15 PM Lunch Break
EXTRA
Breakout Sessions *
12:15 PM Identifying and Managing Women at High Risk of Developing Breast Cancer
Chair: William Gradishar, MD
SESSION 5
Current Issues in Surgery and Adjuvant Therapy
Session Chair: Seema Khan, MD
1:30 PM Adjuvant Considerations in Premenopausal Women
Ruth O’Regan, MD
2:00 PM Fat Grafting: Indications, Safety, Results
Malcolm Kell, MD
2:30 PM TN Breast Cancer: Where are we now?
Joyce O’Shaughnessy, MD
3:00 PM Break
3:30 PM Oncoplastic Surgery or Mastectomy and Reconstruction: Which is the Best Choice?
Elizabeth Mittendorf, MD, PhD
4:00 PM What is the Optimal Duration of Endocrine Therapy?
William Gradishar, MD
4:30 PM Making Endocrine Therapy Better
V. Craig Jordan, OBE, PhD, DSc
5:00 PM Q&A
5:15 PM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts

Saturday, September 16

7:30 AM Breakfast & Exhibits
SESSION 6
Challenging Clinical Scenarios
Session Chair: Massimo Cristofanilli, MD
8:30 AM Overcoming Resistance in ER+ Disease
Massimo Cristofanilli, MD
9:00 AM Surgery or RT for Oligometastases
Thomas Bucholz, MD
9:30 AM Sequencing of HER-2 Therapy
Harold Burstein, MD, PhD
10:00 AM Break
10:30 AM Controversies in DCIS Management
Richard Bleicher, MD
11:00 AM Q&A
11:15 AM THE CONNIE MOSKOW MEMORIAL LECTURE
Breast Cancer as a Global Disease - Are We Up to the Challenge?
Benjamin Anderson, MD
EXTRA
Breakout Sessions *
12:15 PM Challenging Cases Focusing on Local Therapy Issues
Chair: Nora Hansen, MD
12:15 PM Lunch Break
SESSION 7
Breast Cancer in the Elderly and Reconstructive Issues
Session Chair: Monica Morrow, MD
1:30 PM Why Do We Need Geriatric Assessment?
Arti Hurria, MD
1:50 PM Local Therapy Issues in Elders
Kevin Hughes, MD
2:10 PM Adjuvant Therapy for HER-2+ and TN cancer in Elders
Hyman Muss, MD
2:30 PM Choosing the "Right" Breast Reconstruction: Navigating the Cacophony of New Techniques and Technologies in 2017
John Kim, MD
2:50 PM Reconstruction and Radiation
Reshma Jagsi, MD
3:10 PM Q&A
3:30 PM Break
3:45 PM Multidisciplinary Tumor Board
Confirmed Faculty
5:00 PM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts

Sunday, September 17

7:30 AM Breakfast
SESSION 8
Neoadjuvant Controversies
Session Chair: William Gradishar, MD
8:30 AM Predicting Response to NAC
Melinda Telli, MD
9:00 AM Selecting Operable Patients for Primary Surgery vs NAC
Monica Morrow, MD
9:30 AM Managing Residual Disease after NAC
Eleftherios Mamounas, MD, MPH
10:00 AM RT after NAC: What to Do While Awaiting Trial Results?
Abram Recht, MD
11:00 AM Adjourn

View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts

Breakout

Breakout Sessions offer 1.25 CME credits/session, cost $50/session, and have a limited number of seats. Sessions will take place in the Marriott Ballroom on the 4th floor.

Identifying and Managing Women at High Risk of Developing Breast Cancer

Friday, September 15 • 12:15 p.m. - 1:30 p.m.

Chair:

William Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Faculty:

Virginia Kaklamani, MD
UT Health San Antonio Cancer Center

Mark Robson, MD
Memorial Sloan Kettering Cancer Center

Objectives

  1. New high and moderately penetrant breast cancer genes
  2. The basics of cancer susceptibility gene panel testing
  3. What's new in variant classification (VUS)
  4. Strategies for risk-reduction in high-risk women

Challenging Cases Focusing on Local Therapy Issues

Saturday, September 16 • 12:15 p.m. - 1:30 p.m.

Chair:

Nora Hansen, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Faculty:

Richard Bleicher MD
Fox Chase Cancer Center

Mehra Golshan, MD
Dana-Farber Cancer Institute

Objectives

  1. Describe the optimal management strategies for the axilla in patients presenting with different clinical scenarios
  2. Select the optimal radiation therapy approach for patients with stage I-III breast cancer
  3. Explain the clinical utility of molecular markers to determine prognosis and local therapy treatment choices

*Lunch during the session is available for purchase at the Registration Desk for an additional fee.


View more agendas: Thursday | Friday | Saturday | Sunday | Breakouts

THE PROGRAM

The Lurie Cancer Center's Lynn Sage Breast Cancer Symposium offers 3.5 days of formal presentations and case discussions.

BREAKOUT SESSIONS

* Extra breakout session presentations will be available for an additional registration fee. Learn more about this year's breakout sessions

FACULTY

The Lynn Sage Breast Cancer Symposium is proud of its tradition of attracting a faculty comprised of experts from around the world. Faculty list

NON-CME EDUCATIONAL ACTIVITIES

Three optional, non-CME educational activities are scheduled during times that do not conflict with the Symposium agenda.

Details »

© 2016 Robert H. Lurie Comprehensive Cancer Center